Pasithea Therapeutics Corp. (KTTAW)
2025-06-30 | ||||
|---|---|---|---|---|
| Foreign currency translation | 5,631 | |||
| Provision for income taxes | - | |||
| Research and development | 2,148,676 | |||
| General and administrative | 1,662,223 | |||
| Loss from operations | -3,810,899 | |||
| Other income | 19,464 | |||
| Interest and dividends, net | 54,424 | |||
| Realized foreign currency translation loss from dissolution of subsidiaries | - | |||
| Foreign currency gain | 29,290 | |||
| Change in fair value of warrant liabilities | 8,436 | |||
| Other income, net | 94,742 | |||
| Loss before income taxes | -3,716,157 | |||
| Net loss | -3,716,157 | |||
| Comprehensive loss | -3,710,526 | |||
| Basic loss per share (in dollars per share) | -0.66 | |||
| Diluted loss per share (in dollars per share) | -0.66 | |||
| Weighted-average common shares outstanding, basic (in shares) | 5,641,251 | |||
| Weighted-average common shares outstanding, diluted (in shares) | 5,641,251 | |||